Huadong Medicine Co Ltd (000963) — Tangible Net Worth Ratio
Huadong Medicine Co Ltd (000963) has a Tangible Net Worth Ratio of 79.3% as of September 2025. This metric is calculated by deducting intangible assets (CN¥5.06 Billion) from net assets (CN¥24.50 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital to net assets of Huadong Medicine Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Huadong Medicine Co Ltd Tangible Net Worth Ratio (1997–2024)
This chart shows how Huadong Medicine Co Ltd's Tangible Net Worth Ratio has changed across 28 annual periods from 1997 to 2024. As of September 2025, the ratio stands at 79.3%, reflecting net assets of CN¥24.50 Billion with intangible assets of CN¥5.06 Billion CNY. See Huadong Medicine Co Ltd (000963) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Huadong Medicine Co Ltd (1997–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Huadong Medicine Co Ltd from 1997 to 2024, covering 28 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 000963 market cap.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 80.1% | CN¥23.56 Billion | CN¥4.68 Billion | CN¥37.88 Billion | ▼ -4.4 pp |
| 2023 | 84.6% | CN¥21.58 Billion | CN¥3.33 Billion | CN¥33.51 Billion | ▼ -0.2 pp |
| 2022 | 84.8% | CN¥19.18 Billion | CN¥2.92 Billion | CN¥31.19 Billion | ▼ -2.1 pp |
| 2021 | 86.8% | CN¥16.94 Billion | CN¥2.23 Billion | CN¥27.00 Billion | ▼ -3.5 pp |
| 2020 | 90.4% | CN¥15.18 Billion | CN¥1.46 Billion | CN¥24.20 Billion | ▲ +1.7 pp |
| 2019 | 88.7% | CN¥12.87 Billion | CN¥1.45 Billion | CN¥21.46 Billion | ▲ +3.2 pp |
| 2018 | 85.5% | CN¥10.43 Billion | CN¥1.51 Billion | CN¥19.22 Billion | ▼ -7.5 pp |
| 2017 | 93.1% | CN¥8.81 Billion | CN¥609.84 Million | CN¥15.99 Billion | ▼ -0.5 pp |
| 2016 | 93.6% | CN¥7.64 Billion | CN¥490.88 Million | CN¥14.46 Billion | ▲ +5.3 pp |
| 2015 | 88.3% | CN¥3.24 Billion | CN¥380.81 Million | CN¥11.42 Billion | ▼ -0.2 pp |
| 2014 | 88.5% | CN¥2.52 Billion | CN¥290.06 Million | CN¥9.01 Billion | ▼ -1.0 pp |
| 2013 | 89.5% | CN¥3.02 Billion | CN¥317.98 Million | CN¥7.67 Billion | ▼ -0.1 pp |
| 2012 | 89.6% | CN¥2.34 Billion | CN¥244.17 Million | CN¥6.54 Billion | ▲ +3.9 pp |
| 2011 | 85.7% | CN¥1.79 Billion | CN¥256.49 Million | CN¥5.84 Billion | ▼ -1.7 pp |
| 2010 | 87.4% | CN¥1.35 Billion | CN¥170.06 Million | CN¥4.26 Billion | ▼ -3.5 pp |
| 2009 | 90.9% | CN¥1.29 Billion | CN¥117.80 Million | CN¥3.57 Billion | ▼ -1.5 pp |
| 2008 | 92.4% | CN¥892.80 Million | CN¥68.08 Million | CN¥3.09 Billion | ▲ +1.1 pp |
| 2007 | 91.2% | CN¥684.27 Million | CN¥59.94 Million | CN¥2.50 Billion | ▼ -2.0 pp |
| 2006 | 93.3% | CN¥728.30 Million | CN¥49.13 Million | CN¥2.33 Billion | ▲ +1.5 pp |
| 2005 | 91.7% | CN¥686.99 Million | CN¥56.96 Million | CN¥2.05 Billion | ▼ -2.4 pp |
| 2004 | 94.1% | CN¥648.91 Million | CN¥38.30 Million | CN¥1.77 Billion | ▲ +1.1 pp |
| 2003 | 93.0% | CN¥637.95 Million | CN¥44.54 Million | CN¥1.43 Billion | ▲ +0.7 pp |
| 2002 | 92.4% | CN¥607.81 Million | CN¥46.48 Million | CN¥1.37 Billion | ▼ -5.2 pp |
| 2001 | 97.5% | CN¥578.05 Million | CN¥14.32 Million | CN¥1.24 Billion | ▲ +0.4 pp |
| 2000 | 97.1% | CN¥516.34 Million | CN¥14.81 Million | CN¥1.14 Billion | ▲ +0.2 pp |
| 1999 | 96.9% | CN¥502.91 Million | CN¥15.47 Million | CN¥1.00 Billion | ▲ +4.1 pp |
| 1998 | 92.8% | CN¥224.63 Million | CN¥16.13 Million | CN¥691.10 Million | ▼ -7.2 pp |
| 1997 | 100.0% | CN¥202.11 Million | CN¥0.00 | CN¥628.23 Million | — |